Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
product_txtF_mv:"National Center for Biotechnology Information"
Showing
101
-
120
of
204
Search:
''
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
101
Optimal use of minimally invasive glaucoma surgery: A health technology assessment : project protocol
Published 2018
CADTH
Read Now
102
CADTH Canadian drug expert committee recommendation: Benralizumab (Fasenra -- Astrazeneca Canada Inc.) : indication : severe eosinophilic asthma
Published 2018
CADTH
Read Now
103
Pharmacoeconomic review report: Savuconazole (Cresemba) (AVIR pharma inc.)
Published 2019
CADTH
Read Now
104
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
105
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
106
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
Read Now
107
CADTH Canadian Drug Expert Committee recommendation: Sucroferric oxyhydroxide (Velphoro -- Vifor Fresenius Medical Care Renal Pharma Ltd.) : indication : for the control of serum p...
Published 2019
CADTH
Read Now
108
CADTH Canadian Drug Expert Committee recommendation: Edaravone (Radicava -- Mitsubishi Tanabe Pharma Corporation) : indication : for the treatment of amyotrophic lateral sclerosis
Published 2019
CADTH
Read Now
109
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2019
CADTH
Read Now
110
CADTH Canadian Drug Expert Review Committee final recommendation: Adalimumab (Humira -- abbVie) : indication: ulcerative colitis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
111
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Read Now
112
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
113
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
114
CADTH Canadian Drug Expert Committee recommendation: Brexpiprazole (Rexulti - Lundbeck Canada Inc and Otsuka Canada Pharmaceutical Inc.) : indication : treatment of schizophrenia i...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
115
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
116
CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...
Published 2018
CADTH
Read Now
117
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
Read Now
118
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
Read Now
119
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
Read Now
120
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
610 - Medicine & health
192
330 - Economics
111
140 - Specific philosophical schools
24
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
2
800 - Literature & rhetoric
2
Language
English
204
Collection
National Center for Biotechnology Information
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
152
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=6&filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&type=AllFields
Send by Email
×
Loading...